Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFß) Production in Regulatory T-Cells. (2018)

First Author: Powell J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.8b00210

PubMed Identifier: 29648813

Publication URI: http://europepmc.org/abstract/MED/29648813

Type: Journal Article/Review

Volume: 61

Parent Publication: Journal of medicinal chemistry

Issue: 9

ISSN: 0022-2623